ATE85519T1 - Waesserige pharmazeutische ueberzuege fuer dosierformen. - Google Patents

Waesserige pharmazeutische ueberzuege fuer dosierformen.

Info

Publication number
ATE85519T1
ATE85519T1 AT89303289T AT89303289T ATE85519T1 AT E85519 T1 ATE85519 T1 AT E85519T1 AT 89303289 T AT89303289 T AT 89303289T AT 89303289 T AT89303289 T AT 89303289T AT E85519 T1 ATE85519 T1 AT E85519T1
Authority
AT
Austria
Prior art keywords
dosage forms
aqueous pharmaceutical
pharmaceutical coatings
coat
coatings
Prior art date
Application number
AT89303289T
Other languages
English (en)
Inventor
David Emil Edgren
Felix Theeuwes
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ATE85519T1 publication Critical patent/ATE85519T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
AT89303289T 1988-04-28 1989-04-04 Waesserige pharmazeutische ueberzuege fuer dosierformen. ATE85519T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/187,621 US4931285A (en) 1988-04-28 1988-04-28 Aqueous based pharmaceutical coating composition for dosage forms
EP89303289A EP0339811B1 (de) 1988-04-28 1989-04-04 Wässerige pharmazeutische Überzüge für Dosierformen

Publications (1)

Publication Number Publication Date
ATE85519T1 true ATE85519T1 (de) 1993-02-15

Family

ID=22689748

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89303289T ATE85519T1 (de) 1988-04-28 1989-04-04 Waesserige pharmazeutische ueberzuege fuer dosierformen.

Country Status (11)

Country Link
US (1) US4931285A (de)
EP (1) EP0339811B1 (de)
JP (1) JP2581798B2 (de)
AT (1) ATE85519T1 (de)
CA (1) CA1337275C (de)
DE (1) DE68904801T2 (de)
DK (1) DK205889A (de)
ES (1) ES2053981T3 (de)
GR (1) GR3007032T3 (de)
IE (1) IE62132B1 (de)
PT (1) PT90418B (de)

Families Citing this family (99)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5024842A (en) * 1988-04-28 1991-06-18 Alza Corporation Annealed coats
US5126146A (en) * 1989-10-23 1992-06-30 Merck & Co., Inc. Cellulosic coating
US5643591A (en) * 1991-01-16 1997-07-01 Fmc Corporation Solid dosage forms
EP0567541B1 (de) * 1991-01-16 1998-10-07 Fmc Corporation Träger für wirkstoffe und damit hergestellte feste darreichungsformen
US5178867A (en) * 1991-08-19 1993-01-12 Alza Corporation Dosage form for delivering drug in short-time period
GB9311191D0 (en) * 1993-05-29 1993-07-14 Danbiosyst Uk Controlled release drug formulation
GB9609094D0 (en) * 1996-05-01 1996-07-03 Univ Strathclyde Delivery device
US6919373B1 (en) 1996-11-12 2005-07-19 Alza Corporation Methods and devices for providing prolonged drug therapy
US7060734B1 (en) 1997-09-09 2006-06-13 Alza Corporation Pharmaceutical coating composition and method of use
WO1999012526A1 (en) * 1997-09-09 1999-03-18 Alza Corporation Pharmaceutical coating composition and method of use
US6514530B2 (en) * 1997-09-09 2003-02-04 Alza Corporation Dosage form comprising means for changing drug delivery shape
IN186245B (de) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
DK1035834T3 (da) * 1997-12-05 2002-07-08 Alza Corp Osmotisk doseringsform omfattende en første og anden coating
ATE223208T1 (de) * 1997-12-22 2002-09-15 Alza Corp Membranen zur steuerung des durchflusses in vorrichtungen mit kontrollierter wirkstoffabgabe
CN1325301A (zh) 1998-11-02 2001-12-05 阿尔扎有限公司 活性物质的控制释放
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6635281B2 (en) 1998-12-23 2003-10-21 Alza Corporation Gastric retaining oral liquid dosage form
US6342249B1 (en) 1998-12-23 2002-01-29 Alza Corporation Controlled release liquid active agent formulation dosage forms
JP3672008B2 (ja) * 1999-01-20 2005-07-13 シオノギクオリカプス株式会社 硬質カプセル及びその製造方法
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
JP2004531467A (ja) 2000-11-28 2004-10-14 エフ　エム　シー　コーポレーション 可食性ｐｇａ被覆組成物
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
GB0114746D0 (en) * 2001-06-16 2001-08-08 Boots Co Plc Medicinal composition
JP4848101B2 (ja) 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
US8329217B2 (en) 2001-11-06 2012-12-11 Osmotica Kereskedelmi Es Szolgaltato Kft Dual controlled release dosage form
US20030185882A1 (en) * 2001-11-06 2003-10-02 Vergez Juan A. Pharmaceutical compositions containing oxybutynin
JP4031232B2 (ja) * 2001-11-09 2008-01-09 カプスゲル・ジャパン株式会社 新規カプセル
IL162294A0 (en) * 2001-12-19 2005-11-20 Alza Corp Formulation & dosage form for the controlled delivery of therapeutic agents
NZ533060A (en) * 2001-12-19 2006-03-31 Alza Corp Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
EP1499291B1 (de) * 2002-04-29 2009-01-07 ALZA Corporation Methoden und darreichungsformen zur kontrollierten freisetzung von oxykodon
IL165361A0 (en) * 2002-05-31 2006-01-15 Alza Corp Dosage forms and compositions for osmotic deliveryof variable dosages of oxycodone
AR039744A1 (es) * 2002-06-26 2005-03-09 Alza Corp Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
US20050232995A1 (en) * 2002-07-29 2005-10-20 Yam Nyomi V Methods and dosage forms for controlled delivery of paliperidone and risperidone
NZ537543A (en) * 2002-07-29 2007-08-31 Alza Corp Formulations and high dose osmotic dosage forms for controlled delivery of topiramate
CH696420A5 (de) * 2002-09-13 2007-06-15 Mepha Ag Neue stabile Zubereitungen von Alkyl-, Phenyl-Pyridonen für topische Anwendung.
JP2006507309A (ja) * 2002-10-31 2006-03-02 アルザ・コーポレーシヨン 疎水性薬剤の上昇した生物学的利用性を提供する製剤
CN101797221B (zh) 2002-12-13 2013-06-12 杜雷科特公司 包含高粘度液体载体材料的口服递药系统
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
WO2004064772A2 (en) * 2003-01-14 2004-08-05 Alza Corporation Methods and dosage forms with modified viscosity layers
EP1592410B1 (de) * 2003-02-11 2008-07-23 Alza Corporation Verfahren und dosierformen mit modifizierter schichtgeometrie
CA2534920A1 (en) * 2003-08-06 2005-02-24 Alza Corporation Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
WO2005020957A2 (en) * 2003-08-22 2005-03-10 Alza Corporation Stepwise delivery of topiramate over prolonged period of time
US20050069587A1 (en) * 2003-09-02 2005-03-31 Modi Nishit Bachulal Novel drug compositions and dosage forms of topiramate
NZ546182A (en) * 2003-09-26 2009-08-28 Alza Corp Controlled release formulations of opioid and nonopioid analgesics such as hydrocodone and acetaminophen
WO2005030180A1 (en) * 2003-09-26 2005-04-07 Alza Corporation Osmotic dosage forms for controlled delivery of alprazolam
MXPA06003452A (es) * 2003-09-26 2006-08-31 Johnson & Johnson Formulaciones de liberacion controlada que exhiben una velocidad de liberacion ascendente.
EP2184058B1 (de) 2003-09-26 2012-02-08 ALZA Corporation Arzneistoffcoating mit hohem Wirkstoffanteil sowie Methoden zu dessen Herstellung
DE602004032149D1 (de) * 2003-09-26 2011-05-19 Alza Corp Oros-push-stick für die kontrollierte abgabe von wirkstoffen
JP2007511519A (ja) * 2003-11-14 2007-05-10 アルザ・コーポレーシヨン 液状投薬形態物におけるトピラメートの制御放出
CA2549225A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
CA2547597A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
RU2006119464A (ru) * 2003-12-04 2007-12-20 Пфайзер Продактс Инк. (Us) Способ распыления-охлаждения с применением экструдера для получения композиций азитромицина в мультичастицах, предпочтительно содержащих полоксамер и глицерид
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
KR20060092281A (ko) * 2003-12-04 2006-08-22 화이자 프로덕츠 인크. 액체 기초 방법에 의한 아지트로마이신 복합입자 투여형
AU2004294817B2 (en) * 2003-12-04 2007-01-25 Pfizer Products Inc. Method for making pharmaceutical multiparticulates
US20050169992A1 (en) * 2003-12-23 2005-08-04 Frank Jao Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
US20050175696A1 (en) * 2003-12-29 2005-08-11 David Edgren Drug granule coatings that impart smear resistance during mechanical compression
EP1701706A2 (de) * 2003-12-29 2006-09-20 Alza Corporation Neue arzneimittelzusammensetzungen und dosierformen
CA2550699A1 (en) * 2003-12-29 2005-07-21 Alza Corporation, Inc. Novel drug compositions and dosage forms of topiramate
WO2006007323A2 (en) * 2004-06-28 2006-01-19 Alza Corporation Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
WO2006023286A2 (en) * 2004-08-19 2006-03-02 Alza Corporation Controlled release nanoparticle active agent formulation dosage forms and methods
US8541026B2 (en) * 2004-09-24 2013-09-24 Abbvie Inc. Sustained release formulations of opioid and nonopioid analgesics
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
US7959938B2 (en) * 2005-03-15 2011-06-14 Intarcia Therapeutics, Inc. Polyoxaester suspending vehicles for use with implantable delivery systems
KR20080005429A (ko) * 2005-04-19 2008-01-11 알자 코포레이션 트라마돌 및 가바펜틴을 포함하는 물질의 배합물
EP1904030A2 (de) * 2005-06-29 2008-04-02 Alza Corporation Semipermeable zusammensetzungen zur ermöglichung einer reduzierten trocknungszeit für osmotische dosierungsformen
DE102005031577A1 (de) 2005-07-06 2007-01-11 Bayer Healthcare Ag Pharmazeutische Darreichungsformen enthaltend eine Wirkstoffkombination von Nifedipin und/oder Nisoldipin und einem Angiotensin-II Antagonisten
AR055099A1 (es) * 2005-07-28 2007-08-08 Alza Corp Formulaciones liquidas para la administracion controlada de derivados de bencisoxazol
WO2007019393A2 (en) * 2005-08-04 2007-02-15 Alza Corporation Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
EP1933811A2 (de) * 2005-09-30 2008-06-25 Alza Corporation Gebundene nanoteilchenförmige dosierformen einer wirkstoffformulierung mit kontrollierter freisetzung und verfahren
PL116330U1 (en) 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
US20070196487A1 (en) * 2006-02-16 2007-08-23 Geerke Johan H Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
CA2651855C (en) 2006-05-30 2011-08-02 Intarcia Therapeutics, Inc. Two-piece, internal-channel osmotic delivery system flow modulator
WO2008021133A2 (en) 2006-08-09 2008-02-21 Intarcia Therapeutics, Inc. Osmotic delivery systems and piston assemblies
WO2008042802A2 (en) * 2006-09-29 2008-04-10 Sensient Pharmaceutical Technologies Inc. Wet edible pearlescent film coatings
EP2099312B1 (de) 2006-12-14 2016-05-04 Sensient Colors LLC Perlmuttpigmentzusammensetzungen sowie verfahren zu ihrer herstellung und verwendung
US8524749B2 (en) * 2007-02-09 2013-09-03 Alza Corporation Controlled release compositions of tizanidine
ES2402172T3 (es) 2007-04-23 2013-04-29 Intarcia Therapeutics, Inc Formulación en suspensión de péptidos insulinotrópicos y usos de los mismos
JP2011506319A (ja) 2007-12-06 2011-03-03 デュレクト コーポレーション 疼痛、関節炎症状、または慢性疾患に伴う炎症の治療に有用な方法
DK2240155T3 (da) 2008-02-13 2012-09-17 Intarcia Therapeutics Inc Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
DE102008059206A1 (de) 2008-11-27 2010-06-10 Bayer Schering Pharma Aktiengesellschaft Pharmazeutische Darreichungsform enthaltend Nifedipin oder Nisoldipin und einen Angiotensin-II Antagonisten und/oder ein Diuretikum
LT2462246T (lt) 2009-09-28 2017-11-27 Intarcia Therapeutics, Inc Esminio stacionaraus vaisto tiekimo greitas įgyvendinimas ir (arba) nutraukimas
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
ES2612532T3 (es) 2012-05-07 2017-05-17 Bayer Pharma Aktiengesellschaft Procedimiento de fabricación de una forma de dosificación farmacéutica que comprende nifedipina y candesartán cilexetilo
JP2016515523A (ja) 2013-03-15 2016-05-30 デュレクト コーポレーション 溶解変動性を低減させるためのレオロジー改質剤を有する組成物
WO2016040650A1 (en) * 2014-09-10 2016-03-17 University Of Rochester Soluble guanylyl cyclase inhibition effects on lymphatic vasculature
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
US10501517B2 (en) 2016-05-16 2019-12-10 Intarcia Therapeutics, Inc. Glucagon-receptor selective polypeptides and methods of use thereof
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
AU2017292791B2 (en) 2016-07-06 2023-05-25 Orient Pharma Co., Ltd. Oral dosage form with drug composition, barrier layer and drug layer
IL267736B2 (en) 2017-01-03 2024-03-01 Intarcia Therapeutics Inc Methods comprising continuous administration of a glp-1 receptor agonist and co-adminstration of a drug

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2799241A (en) * 1949-01-21 1957-07-16 Wisconsin Alumni Res Found Means for applying coatings to tablets or the like
US3865108A (en) * 1971-05-17 1975-02-11 Ortho Pharma Corp Expandable drug delivery device
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916889A (en) * 1973-09-28 1975-11-04 Sandoz Ag Patient ventilator apparatus
ZA753851B (en) * 1974-08-01 1976-05-26 Ici Ltd Film coating process
GB1478759A (en) * 1974-11-18 1977-07-06 Alza Corp Process for forming outlet passageways in pills using a laser
US4002174A (en) * 1975-10-14 1977-01-11 Texas Medical Products, Inc. Air embolus aspirator
US4077407A (en) * 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4014334A (en) * 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4063064A (en) * 1976-02-23 1977-12-13 Coherent Radiation Apparatus for tracking moving workpiece by a laser beam
US4207893A (en) * 1977-08-29 1980-06-17 Alza Corporation Device using hydrophilic polymer for delivering drug to biological environment
US4285987A (en) * 1978-10-23 1981-08-25 Alza Corporation Process for manufacturing device with dispersion zone
US4200098A (en) * 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4327725A (en) * 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4369172A (en) * 1981-12-18 1983-01-18 Forest Laboratories Inc. Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
GB2170104A (en) * 1985-01-30 1986-07-30 Warner Lambert Co Coated pharmaceutical dosage forms

Also Published As

Publication number Publication date
IE891116L (en) 1989-10-28
EP0339811A3 (en) 1990-11-07
EP0339811B1 (de) 1993-02-10
JPH0211526A (ja) 1990-01-16
IE62132B1 (en) 1994-12-14
US4931285A (en) 1990-06-05
JP2581798B2 (ja) 1997-02-12
GR3007032T3 (de) 1993-07-30
PT90418A (pt) 1989-11-10
DK205889A (da) 1989-10-29
DE68904801D1 (de) 1993-03-25
DK205889D0 (da) 1989-04-27
ES2053981T3 (es) 1994-08-01
PT90418B (pt) 1994-05-31
DE68904801T2 (de) 1993-05-27
EP0339811A2 (de) 1989-11-02
CA1337275C (en) 1995-10-10

Similar Documents

Publication Publication Date Title
ATE85519T1 (de) Waesserige pharmazeutische ueberzuege fuer dosierformen.
DE68902954D1 (de) Waessrige ueberzugsemulsion fuer pharmazeutische dosierungsformen.
DE3650657D1 (de) Pharmazeutische Formulierung mit gesteuerter Freigabe
FI903925A7 (fi) Painettu annostelulaite lääkkeen annostelemiseksi ihon läpi
MX9203755A (es) Dispositivo de suministro iontoforetico de drogas o agentes terapeuticos, dotado de un adhesivo de electrotransporte.
DE59308338D1 (de) Kosmetische oder pharmazeutische Zubereitungen
IT1236320B (it) Dispositivo per la nebulizzazione ultrasonica di fluidi, per inalazione respiratoria ed altro
NO892826D0 (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat for aa forhindre seksuelt overfoerbare sykdommer.
NO306619B1 (no) Farmasöytisk preparat inneholdende en hemmer av testosteron 5<alfa>-reduktaseaktivitet samt anvendelse av slik hemmer for fremstilling av et legemiddel
DE68902300D1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.
DE68912341D1 (de) Pharmazeutische zusammensetzungen mit gehalt an calcitonin zur intranasalen verabreichung und eine spray-einheit zur verabreichung derselben.
NO179396C (no) Fremgangsmåte ved fremstilling av en medikamentell administreringsform for drövtyggere
NO924151L (no) Komplekse salter av hematoporfyrin, derivater derav, fremgangsmaate for fremstilling samt terapeutisk anvendelse
PT89920A (pt) Processo para a preparacao de um sistema de administracao de substancias activas por via oral com libertacao controlada das substancias activas
DK298389D0 (da) Farmaceutisk praeparat til topisk anvendelse omfattende et amin-funktionelt medikament
DE69115528D1 (de) Neue pharmazeutische Verwendungen von Forskolin-Derivaten
NO920313D0 (no) Fremgangsmaate for fremstilling av rasemisk og optisk aktiv 1,2,3,4-tetrahydroisokinolin-3-karbonsyre samt forprodukter derav
ATE86118T1 (de) Virushemmende pharmazeutische zusammensetzung.
ATA321188A (de) Pharmazeutische zubereitung
ITMI921573A0 (it) Dispositivo di somministrazione di farmaci particolarmente per aerosolterapia e simili
IT8841650A0 (it) Videorefrattometro a luce infrarossa particolarmewnte per applicazioni in oftalmologia pediatrica
WO1992019209A3 (en) Taste-masked medicaments and their preparation
IT214895Z2 (it) Dispositivo nebulizzatore per smalti e simili
FR2578402B1 (fr) Dispositif de conditionnement de medicaments du type " semainier "
ATE78684T1 (de) Pharmazeutische loesung enthaltend salbutamol und cromoglycinsaeure.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee